130 Overall survival benefit and impact on skeletal-related events for radium-223 chloride (Alpharadin) in the treatment of castration-resistant prostate cancer (CRPC) patients with bone metastases: A phase III randomized trial (ALSYMPCA)
暂无分享，去创建一个
S. Fosså | C. Parker | N. James | P. Hoskin | J. Logue | S. Nilsson | D. Bottomley | O. Sartor | J. Kliment | J. O’Sullivan | I. Syndikus | S. Wedel | A. Widmark | D. Heinrich | S. Helle | A. Chodacki | M. Seke | D. Johannessen | A. Solberg | C. G. O'Bryan-Tear | J. Garcia-Vargas | T. Demkow | A. Cross